Tetra Therapeutics Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$500M
Tetra Therapeutics General Information
Description
Operator of a clinical-stage biotechnology company intended to develop drugs for brain-related diseases. The company specializes in the development of drugs for neurological conditions include allosteric inhibitors of phosphodiesterase, an enzyme in the brain that controls the biochemical process of memory research, enabling hospitals to treat Alzheimer's disease, traumatic brain injury and schizophrenia in an efficient manner.
Contact Information
Website
www.tetratherapeutics.com(Operating Subsidiary)
Corporate Office
- 2220 Wealthy Street South East
- Grand Rapids, MI 49506
- United States
Corporate Office
- 2220 Wealthy Street South East
- Grand Rapids, MI 49506
- United States
Tetra Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 05-Mar-2020 | $500M | Completed | Clinical Trials - Phase 2 | ||
| 11. Grant | 08-Dec-2019 | Completed | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC (Series B) | 03-Jan-2019 | Completed | Clinical Trials - Phase 2 | |||
| 9. Grant | 01-Jan-2018 | Completed | Clinical Trials - Phase 1 | |||
| 8. Grant | 14-Jun-2017 | Completed | Clinical Trials - Phase 2 | |||
| 7. Grant | 29-Nov-2016 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC (Series A) | 29-Jul-2016 | Completed | Clinical Trials - Phase 1 | |||
| 5. Grant | 01-Jan-2015 | Completed | Startup | |||
| 4. Grant | 01-Aug-2013 | $4M | Completed | Startup | ||
| 3. Angel (individual) | 01-Jan-2013 | Completed | Startup |
Tetra Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Tetra Therapeutics Comparisons
Industry
Financing
Details
Tetra Therapeutics Competitors (48)
One of Tetra Therapeutics’s 48 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| Alzheon | Venture Capital-Backed | Framingham, MA | ||||
| Bioasis Technologies | Corporation | Guilford, CT | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| T3D Therapeutics | Venture Capital-Backed | Durham, NC |
Tetra Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Tetra Therapeutics Patents
Tetra Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11104660-B2 | Pde4d inhibitors | Active | 23-Apr-2019 | ||
| US-20200339532-A1 | Pde4d inhibitors | Active | 23-Apr-2019 | ||
| EP-3959203-A1 | 3-hydroxy-2-phenyl-6-(pyrazol-4-ylmethyl)pyridine derivatives as pde4d inhibitors | Pending | 23-Apr-2019 | ||
| EP-3956311-A1 | Salts and polymorphs of a pde4 inhibitor | Pending | 18-Apr-2019 | ||
| US-20200331858-A1 | Salts and polymorphs of a pde4 inhibitor | Active | 18-Apr-2019 | C07D213/55 |
Tetra Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Tetra Therapeutics Former Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | Minority | ||
| Apjohn Group | Venture Capital | Minority | ||
| Biosciences Research and Commercialization Center | Venture Capital | Minority | ||
| Dolby Family Ventures | Venture Capital | Minority | ||
| Grand Angels | Angel Group | Minority |
Tetra Therapeutics FAQs
-
When was Tetra Therapeutics founded?
Tetra Therapeutics was founded in 2010.
-
Where is Tetra Therapeutics headquartered?
Tetra Therapeutics is headquartered in Grand Rapids, MI.
-
What is the size of Tetra Therapeutics?
Tetra Therapeutics has 7 total employees.
-
What industry is Tetra Therapeutics in?
Tetra Therapeutics’s primary industry is Drug Discovery.
-
Is Tetra Therapeutics a private or public company?
Tetra Therapeutics is a Private company.
-
What is the current valuation of Tetra Therapeutics?
The current valuation of Tetra Therapeutics is .
-
What is Tetra Therapeutics’s current revenue?
The current revenue for Tetra Therapeutics is .
-
How much funding has Tetra Therapeutics raised over time?
Tetra Therapeutics has raised $40M.
-
Who are Tetra Therapeutics’s investors?
Alzheimers Drug Discovery Foundation, Apjohn Group, Biosciences Research and Commercialization Center, Dolby Family Ventures, and Grand Angels are 5 of 18 investors who have invested in Tetra Therapeutics.
-
Who are Tetra Therapeutics’s competitors?
CervoMed, Alzheon, Bioasis Technologies, NeuroNascent, and T3D Therapeutics are some of the 48 competitors of Tetra Therapeutics.
-
When was Tetra Therapeutics acquired?
Tetra Therapeutics was acquired on 05-Mar-2020.
-
Who acquired Tetra Therapeutics?
Tetra Therapeutics was acquired by Shionogi & Co..
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
